These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7013473)

  • 1. Fatal veno-occlusive disease of the liver following high-dose 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and autologous bone marrow transplantation.
    McIntyre RE; Magidson JG; Austin GE; Gale RP
    Am J Clin Pathol; 1981 Apr; 75(4):614-7. PubMed ID: 7013473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intensive 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), NSC #4366650 and cryopreserved autologous marrow transplantation for refractory cancer. A phase I-II study.
    Phillips GL; Fay JW; Herzig GP; Herzig RH; Weiner RS; Wolff SN; Lazarus HM; Karanes C; Ross WE; Kramer BS
    Cancer; 1983 Nov; 52(10):1792-802. PubMed ID: 6354414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatal veno-occlusive disease of the liver following high dose chemotherapy, irradiation and bone marrow transplantation.
    Woods WG; Dehner LP; Nesbit ME; Krivit W; Coccia PF; Ramsay NK; Kim TH; Kersey JH
    Am J Med; 1980 Feb; 68(2):285-90. PubMed ID: 6986767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolongation of survival for high-grade malignant gliomas with adjuvant high-dose BCNU and autologous bone marrow transplantation.
    Johnson DB; Thompson JM; Corwin JA; Mosley KR; Smith MT; de los Reyes RA; Daly MB; Petty AM; Lamaster D; Pierson WP
    J Clin Oncol; 1987 May; 5(5):783-9. PubMed ID: 3553437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensive 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU) monochemotherapy and autologous marrow transplantation for malignant glioma.
    Phillips GL; Wolff SN; Fay JW; Herzig RH; Lazarus HM; Schold C; Herzig GP
    J Clin Oncol; 1986 May; 4(5):639-45. PubMed ID: 3009725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DeltaMGMT-transduced bone marrow infusion increases tolerance to O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea and allows intensive therapy of 1,3-bis(2-chloroethyl)-1-nitrosourea-resistant human colon cancer xenografts.
    Koç ON; Reese JS; Davis BM; Liu L; Majczenko KJ; Gerson SL
    Hum Gene Ther; 1999 Apr; 10(6):1021-30. PubMed ID: 10223735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early pulmonary toxicity after administration of high-dose BCNU.
    Litam JP; Dail DH; Spitzer G; Vellekoop L; Verma DS; Zander AR; Dicke KA
    Cancer Treat Rep; 1981; 65(1-2):39-44. PubMed ID: 6261949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose carboplatin, cyclophosphamide, and BCNU with autologous bone marrow support: excessive hepatic toxicity.
    Jones RB; Shpall EJ; Ross M; Coniglio D; Affronti ML; Peters WP
    Cancer Chemother Pharmacol; 1990; 26(2):155-6. PubMed ID: 2189592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intensive 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) autologous bone marrow transplantation therapy of refractory cancer: a preliminary report.
    Phillips GL; Fay JW; Herzig GP; NaPombejara C; Wolff SN
    Exp Hematol; 1979; 7 Suppl 5():372-83. PubMed ID: 400699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Four-year survival after trans-jugular intrahepatic porto-systemic shunt for veno-occlusive disease following autologous bone marrow transplantation.
    Annaloro C; Robbiolo L; Pozzoli E; Ibatici A; Nicolini A; Salerno F; Deliliers GL
    Leuk Lymphoma; 2004 Jul; 45(7):1485-7. PubMed ID: 15359654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic venoocclusive disease in autologous bone marrow transplantation of solid tumors and lymphomas.
    Ayash LJ; Hunt M; Antman K; Nadler L; Wheeler C; Takvorian T; Elias A; Antin JH; Greenough T; Eder JP
    J Clin Oncol; 1990 Oct; 8(10):1699-706. PubMed ID: 2213105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose BCNU therapy with autologous bone marrow infusion: preliminary observations.
    Spitzer G; Dicke KA; Verma DS; Zander A; McCredie KB
    Cancer Treat Rep; 1979 Aug; 63(8):1257-64. PubMed ID: 383292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic veno-occlusive disease after high-dose mitomycin C and autologous bone marrow transplantation therapy.
    Gottfried MR; Sudilovsky O
    Hum Pathol; 1982 Jul; 13(7):646-50. PubMed ID: 6806170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autologous bone-marrow transplantation: host effects of high-dose BCNU.
    Takvorian T; Parker LM; Hochberg FH; Canellos GP
    J Clin Oncol; 1983 Oct; 1(10):610-20. PubMed ID: 6366127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal liver function tests following bone marrow transplantation: aetiology and role of liver biopsy.
    Ho GT; Parker A; MacKenzie JF; Morris AJ; Stanley AJ
    Eur J Gastroenterol Hepatol; 2004 Feb; 16(2):157-62. PubMed ID: 15075988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial ischemia associated with high-dose carmustine infusion.
    Kanj SS; Sharara AI; Shpall EJ; Jones RB; Peters WP
    Cancer; 1991 Nov; 68(9):1910-2. PubMed ID: 1655228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignancy-associated pulmonary veno-occlusive disease: report of a case following autologous bone marrow transplantation and review.
    Salzman D; Adkins DR; Craig F; Freytes C; LeMaistre CF
    Bone Marrow Transplant; 1996 Oct; 18(4):755-60. PubMed ID: 8899191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methyl-Guanine-Methyl-Transferase Transgenic Bone Marrow Transplantation Allows N,N-bis(2-chloroethyl)-Nitrosourea Driven Donor Mixed-Chimerism Without Graft-Versus-Host Disease, and With Donor-Specific Allograft Tolerance.
    Hu M; Kramer B; Zhang GY; Wang YM; Watson D; Howden B; McCowage G; Alexander IE; Gunning P; Alexander SI
    Transplantation; 2015 Dec; 99(12):2476-84. PubMed ID: 26177088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increasing DNA repair methyltransferase levels via bone marrow stem cell transduction rescues mice from the toxic effects of 1,3-bis(2-chloroethyl)-1-nitrosourea, a chemotherapeutic alkylating agent.
    Maze R; Carney JP; Kelley MR; Glassner BJ; Williams DA; Samson L
    Proc Natl Acad Sci U S A; 1996 Jan; 93(1):206-10. PubMed ID: 8552605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose BCNU with autologous bone marrow rescue for recurrent glioblastoma multiforme.
    Hochberg FH; Parker LM; Takvorian T; Canellos GP; Zervas NT
    J Neurosurg; 1981 Apr; 54(4):455-60. PubMed ID: 6259300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.